Response to letter by Saver [10]

Stroke

Volumn 38, Issue 2, 2007, Pages 258-

  Koziol, James A ^a   Feng, Anne C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISUFENTON SODIUM; NEW DRUG; NID 001; PLACEBO; UNCLASSIFIED DRUG;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER PROGRAM; CONFIDENCE INTERVAL; HUMAN; INFORMATION; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANK SUM TEST; RANKIN SCALE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE;

EID: 33846569479     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000254536.34500.d2     Document Type: Letter

References (5)

1. Koziol JA, Feng AC. On the analysis and interpretation of outcome measures in stroke clinical trials: lessons from the SAINT I study of NXY-059 for acute ischemic stroke. Stroke. 2006;37:2644-2647.
2. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW. NXY-059 for acute ischemic stroke. New Engl J Med. 2006;354:588-600.
3. The Consort Statement. Available at: www.consort-statement.org Accessed October 10, 2006.
4. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. Brit J Med. 1995;310:452-454.
5. Altman DG. Confidence intervals for the number needed to treat. Brit J Med. 1998;317:1309-1312.